信息
GEXVal Receives EMA’s CHMP Scientific Advice for Lead Pipeline GXV-001
2026年5月21日
株式會社GEXValMay 21, 2026 GEXVal Receives Scientific Advice from EMA’s CHMP for Lead Pipeline GXV-001 in Fragile […]
GEXVal Selected as Presenting Company at BioEquity Europe 2026
2026年5月7日
株式會社GEXValMay 7, 2026 GEXVal CEO Selected to Present at BioEquity Europe 2026 GEXVal Inc. (President & C […]
GEXVal CEO Selected as Invited Speaker at CPHI Japan 2026
2026年4月15日
株式會社GEXValApril 15, 2026 GEXVal CEO Selected as Invited Speaker at Drug Discovery Symposium of CPHI Japan 2026 […]
Announcement of Appointment of External Director
2026年3月25日
株式會社GEXValMarch 25, 2026 Unlocking the Value of Drug Discovery Through IP Strategy — Appointment of of Dr. Kao […]
GEXVal CTO to Present at the Annual Meeting of the PSJ
2026年3月25日
株式會社GEXValMarch 25, 2026 GEXVal CTO to Present at the 146th Annual Meeting of the Pharmaceutical Society of Ja […]